This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Comparison With Cholestyramine Treatment in Type Ila Hyperlipoproteinemia

P. J. Palumbo, MD; Esperanza R. Briones, MS; Ralph A. Nelson, MD

JAMA. 1978;240(3):223-227.

Abstract
Fourteen patients with type Ila hyperlipoproteinemia were treated with a high fiber intake (powdered cellulose or soy hulls or both) for six months. Eight of the patients were treated with 16 g of cholestyramine resin daily without the high fiber intake for an additional six months. The cholesterol intake was comparable in both treatment programs. The mean serum cholesterol levels decreased during both, but the decrease occurred and was more pronounced in all patients treated with cholestyramine. Responsiveness to the high fiber diet was not related to an increased responsiveness to cholestyramine treatment. In most patients the serum triglyceride levels increased, and the fasting plasma glucose level did not change substantially during either treatment program. Both regimens were free of adverse side effects.

(JAMA 240:223-227, 1978)

Author Affiliations
From the Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn.

Footnotes
Reprint requests to Mayo Clinic, 200 First St SW, Rochester, MN 55901 (Dr Palumbo).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High-Molecular-Weight Hydroxypropylmethylcellulose: A Cholesterol-Lowering Agent
Dressman et al.
Arch Intern Med 1993;153:1345-NP.
ABSTRACT